ICYMI: A new pneumococcal vaccine just outperformed Pfizer and Merck in trials #PneumococcalVaccine #Vaxcyte

A new pneumococcal vaccine just outperformed Pfizer and Merck in trials #Vaxcyte #VaccineResearch

Shares in #Vaxcyte have rocketed on the revelation of phase 3 trial data for its #pneumococcalvaccine (PCV) candidate VAX-31, which suggests it could be a threat to already-marketed shots from Pfizer and MSD.

pharmaphorum.com/news/vaxcyte...

BIOTECH · Vaxcyte's vaccine beats rivals in late-stage trial

VAX-31 matched or beat Pfizer's Prevnar 20 head-to-head in a Phase 3 study, sending Vaxcyte's stock soaring.

Read the full story →

#Biotech #Vaxcyte #TheDailyFathom

Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more news.. statnews.com/pharmalot/20... #pharma #vaccine #mergers #Vaxcyte #Novo #mRNA #cancer #Bayer #HIV #India